{"abstract": "The new drug is made by Amgen for people with extremely high cholesterol levels and heart patients who do not get adequate results from statins and other therapies.", "web_url": "https://www.nytimes.com/2015/08/28/health/fda-approves-another-in-a-new-class-of-cholesterol-drugs.html", "snippet": "The new drug is made by Amgen for people with extremely high cholesterol levels and heart patients who do not get adequate results from statins and other therapies.", "lead_paragraph": "The Food and Drug Administration on Thursday approved the second drug in a novel class of powerful cholesterol-lowering medications.", "print_section": "B", "print_page": "3", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "xlarge", "caption": null, "credit": null, "type": "image", "url": "images/2015/08/28/science/28DRUG1/28DRUG1-articleLarge.jpg", "height": 400, "width": 600, "subType": "xlarge", "crop_name": "articleLarge", "legacy": {"xlarge": "images/2015/08/28/science/28DRUG1/28DRUG1-articleLarge.jpg", "xlargewidth": 600, "xlargeheight": 400}}, {"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2015/08/28/science/28DRUG1/28DRUG1-jumbo.jpg", "height": 683, "width": 1024, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "superJumbo", "caption": null, "credit": null, "type": "image", "url": "images/2015/08/28/science/28DRUG1/28DRUG1-superJumbo.jpg", "height": 1365, "width": 2048, "subType": "superJumbo", "crop_name": "superJumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2015/08/28/science/28DRUG1/28DRUG1-thumbStandard-v2.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2015/08/28/science/28DRUG1/28DRUG1-thumbStandard-v2.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}, {"rank": 0, "subtype": "thumbLarge", "caption": null, "credit": null, "type": "image", "url": "images/2015/08/28/science/28DRUG1/28DRUG1-thumbLarge-v2.jpg", "height": 150, "width": 150, "subType": "thumbLarge", "crop_name": "thumbLarge", "legacy": {}}], "headline": {"main": "F.D.A. Approves Repatha, a Second Drug for Cholesterol in a Potent New Class", "kicker": null, "content_kicker": null, "print_headline": "F.D.A. Approves the Second Drug for Cholesterol in a Potent New Class", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "persons", "value": "Kolata, Gina", "rank": 1, "major": "N"}, {"name": "subject", "value": "Cholesterol", "rank": 2, "major": "N"}, {"name": "subject", "value": "Repatha (Drug)", "rank": 3, "major": "N"}, {"name": "organizations", "value": "AMGEN INC", "rank": 4, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 5, "major": "N"}, {"name": "organizations", "value": "Food and Drug Administration", "rank": 6, "major": "N"}, {"name": "subject", "value": "Heart", "rank": 7, "major": "N"}], "pub_date": "2015-08-27T21:28:15+0000", "document_type": "article", "news_desk": "Business", "section_name": "Health", "byline": {"original": "By Gina Kolata", "person": [{"firstname": "Gina", "middlename": null, "lastname": "Kolata", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/9b9bdba9-e905-531c-aebf-ed2c98b28128", "word_count": 898, "uri": "nyt://article/9b9bdba9-e905-531c-aebf-ed2c98b28128"}